PLTR News: Palantir Technologies edges lower despite yet another contract
Premium|Take advantage of 60% OFF on your first month.
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
CLAIM OFFER- NYSE:PLTR fell by 1.01% during a choppy session for growth stocks.
- Palantir and Grupo Globo agreed to a two-year extension of their partnership.
- Palantir was also tasked with joining the NIH in building the largest COVID-19 research database in the world.
NYSE:PLTR has met some resistance the past couple of days, even though the short-term outlook remains in a bullish trend. On Wednesday, Palantir fell for the second straight day, dipping by 1.01% to close the session at $26.36. Once again Palantir failed to breach the $27.49 price level and was quickly rejected after briefly moving into the green during intraday trading. After a recent streak of five consecutive positive days, Palantir has now fallen during consecutive sessions, which can still be seen as bullish consolidation if the price doesn’t fall below key levels like the 9-day or 21-day moving averages.
Stay up to speed with hot stocks' news!
Palantir announced it would be extending its partnership with Grupo Globo, which is Latin America’s largest media company. Grupo Globo utilizes Palantir’s Foundry software platform to provide content to its audience of over 100 million Brazillians each day in 99% of Brazilllian households. Grupo Globo also has an international presence with customers in over 190 countries around the world. The two companies originally joined forces in 2019, and the new agreement will see them work together until at least 2023.
PLTR stock forecast
Palantir also reported that it is teaming up with NIH or the National Institutes of Health to build the largest centralized research database of COVID-19 patient information in the world. With well over 200 different projects, over 2 million patients, and over 7 billion rows of data to analyze, the NIH reached out to Palantir as the leader in global data analytics to organize and create this database. The partnership was awarded the AWS 2021 Global Public Sector Partner Award for Best COVID-19 Solution.
- NYSE:PLTR fell by 1.01% during a choppy session for growth stocks.
- Palantir and Grupo Globo agreed to a two-year extension of their partnership.
- Palantir was also tasked with joining the NIH in building the largest COVID-19 research database in the world.
NYSE:PLTR has met some resistance the past couple of days, even though the short-term outlook remains in a bullish trend. On Wednesday, Palantir fell for the second straight day, dipping by 1.01% to close the session at $26.36. Once again Palantir failed to breach the $27.49 price level and was quickly rejected after briefly moving into the green during intraday trading. After a recent streak of five consecutive positive days, Palantir has now fallen during consecutive sessions, which can still be seen as bullish consolidation if the price doesn’t fall below key levels like the 9-day or 21-day moving averages.
Stay up to speed with hot stocks' news!
Palantir announced it would be extending its partnership with Grupo Globo, which is Latin America’s largest media company. Grupo Globo utilizes Palantir’s Foundry software platform to provide content to its audience of over 100 million Brazillians each day in 99% of Brazilllian households. Grupo Globo also has an international presence with customers in over 190 countries around the world. The two companies originally joined forces in 2019, and the new agreement will see them work together until at least 2023.
PLTR stock forecast
Palantir also reported that it is teaming up with NIH or the National Institutes of Health to build the largest centralized research database of COVID-19 patient information in the world. With well over 200 different projects, over 2 million patients, and over 7 billion rows of data to analyze, the NIH reached out to Palantir as the leader in global data analytics to organize and create this database. The partnership was awarded the AWS 2021 Global Public Sector Partner Award for Best COVID-19 Solution.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.